Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.51 |
| ▸ | GAA | P10253 | 1/20 | 0.51 |
| ▸ | CA1 | P00915 | 2/20 | 0.43 |
| ▸ | CA2 | P00918 | 2/20 | 0.43 |
| ▸ | CA12 | O43570 | 1/20 | 0.42 |
| ▸ | CA7 | P43166 | 1/20 | 0.42 |
| ▸ | CA9 | Q16790 | 1/20 | 0.42 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.42 |
| ▸ | MEN1 | O00255 | 3/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.40 |
| ▸ | LPAR1 | Q92633 | 1/20 | 0.40 |
| ▸ | LMNA | P02545 | 3/20 | 0.39 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.39 |
| ▸ | POLB | P06746 | 1/20 | 0.39 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.39 |
| ▸ | RARA | P10276 | 1/20 | 0.38 |
| ▸ | RARB | P10826 | 1/20 | 0.38 |
| ▸ | RARG | P13631 | 1/20 | 0.38 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.38 |
| ▸ | MAPT | P10636 | 2/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25933559 | 0.82 | CYP3A4 (0.42) | ALDH1A1GAANPSR1L3MBTL1CYP3A4 | |
| SCHEMBL799846 | 0.81 | ALDH1A1 (0.70) | ALDH1A1GAACA1CA2CA12 | |
| SCHEMBL16859696 | 0.80 | CYP3A4 (0.43) | ALDH1A1GAACA1CA2CA9 | |
| SCHEMBL28499495 | 0.80 | ALDH1A1 (0.58) | ALDH1A1GAACA1CA2CA12 | |
| SCHEMBL2281412 | 0.79 | ALDH1A1 (0.43) | ALDH1A1GAACA1CA2CA12 | |
| SCHEMBL1487458 | 0.79 | CYP3A4 (0.44) | ALDH1A1GAACA1CA2CA9 | |
| SCHEMBL29355190 | 0.79 | CA1 (0.42) | ALDH1A1CA1CA2CA9NPSR1 | |
| SCHEMBL82774 | 0.79 | CA1 (0.42) | ALDH1A1CA1CA2CA9NPSR1 | |
| SCHEMBL1725843 | 0.78 | ALDH1A1 (0.57) | ALDH1A1GAACA1CA2CA12 | |
| SCHEMBL25307457 | 0.76 | ALDH1A1 (0.55) | ALDH1A1GAACA1CA2CA12 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20040236133-A1 | Novel phosphite compounds and novel phosphite metal complexes | EVONIK OXENO GMBH (DE) | 2004-11-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040236133-A1 | Novel phosphite compounds and novel phosphite metal complexes | PHOSPHO1, POF1B, PPA1 | ALDH1A1 2998/4885GAA 3161/4885CA1 285/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.